Previous close | 3.380 |
Open | 3.380 |
Bid | 3.540 x 0 |
Ask | 3.550 x 0 |
Day's range | 3.340 - 3.600 |
52-week range | 2.590 - 5.820 |
Volume | |
Avg. volume | 49,026,573 |
Market cap | 57.126B |
Beta (5Y monthly) | 1.03 |
PE ratio (TTM) | 59.17 |
EPS (TTM) | 0.060 |
Earnings date | 27 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.65 |
Amid a backdrop of fluctuating global markets, with the Hang Seng Index recently experiencing significant declines, investors are keenly observing how different sectors and companies navigate these challenging conditions. In this context, growth companies in Hong Kong with high insider ownership present a compelling profile as they often exemplify a strong alignment between management’s interests and shareholder returns, particularly in environments where strategic agility is paramount to...
As global markets navigate through mixed signals, with the Nasdaq reaching new heights while the Dow experiences significant declines, investors are closely monitoring various economic indicators and corporate earnings reports. In this context, understanding the importance of insider ownership in growth companies can provide valuable insights into their potential resilience and alignment of interests between shareholders and management.
Investing.com-- Shares of Alibaba Health Information Technology (HK:0241) rose sharply on Tuesday after the firm clocked a sharp jump in its annual earnings on improved margins and strong demand for healthcare services and pharmaceuticals on its platforms.